Jing Pan

5.8k total citations
142 papers, 4.4k citations indexed

About

Jing Pan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jing Pan has authored 142 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 32 papers in Cancer Research and 26 papers in Oncology. Recurrent topics in Jing Pan's work include Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (11 papers) and MicroRNA in disease regulation (9 papers). Jing Pan is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (11 papers) and MicroRNA in disease regulation (9 papers). Jing Pan collaborates with scholars based in United States, China and Japan. Jing Pan's co-authors include Ming You, Yian Wang, Keiichi Fukuda, Satoshi Ogawa, Hiroaki Kodama, Toshiyuki Takahashi, Qi Zhang, Motoaki Sano, Shinji Makino and Ronald A. Lubet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jing Pan

138 papers receiving 4.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jing Pan 2.5k 915 739 542 493 142 4.4k
Kyung Keun Kim 2.5k 1.0× 678 0.7× 936 1.3× 317 0.6× 207 0.4× 142 4.1k
Melanie Boerries 2.8k 1.1× 1.0k 1.1× 1.3k 1.7× 572 1.1× 318 0.6× 164 4.5k
Jin Zhang 1.9k 0.8× 627 0.7× 780 1.1× 428 0.8× 195 0.4× 131 3.6k
Yu Liu 3.2k 1.3× 948 1.0× 1.7k 2.3× 557 1.0× 208 0.4× 219 5.7k
Dimcho Bachvarov 1.9k 0.8× 439 0.5× 582 0.8× 777 1.4× 258 0.5× 91 3.9k
Yao Chen 2.1k 0.8× 724 0.8× 718 1.0× 1.0k 1.9× 132 0.3× 247 5.2k
Ulrich Pfeffer 3.6k 1.4× 1.2k 1.3× 1.3k 1.7× 860 1.6× 249 0.5× 143 6.3k
Hongmei Li 2.6k 1.0× 937 1.0× 841 1.1× 751 1.4× 174 0.4× 165 4.7k
Keizo Takenaga 3.4k 1.4× 1.5k 1.7× 760 1.0× 679 1.3× 152 0.3× 139 4.8k
Robert S. Geske 2.6k 1.1× 267 0.3× 715 1.0× 376 0.7× 352 0.7× 37 4.5k

Countries citing papers authored by Jing Pan

Since Specialization
Citations

This map shows the geographic impact of Jing Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Pan more than expected).

Fields of papers citing papers by Jing Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Pan. The network helps show where Jing Pan may publish in the future.

Co-authorship network of co-authors of Jing Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Pan. A scholar is included among the top collaborators of Jing Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Pan. Jing Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhicheng, Tao Zhong, F. Xia, et al.. (2025). FDX1 facilitates elesclomol-induced cuproptosis and promotes glioblastoma development via transcription factor NFKB1. Biochemical Pharmacology. 241. 117186–117186. 1 indexed citations
2.
Wang, Pan, Jing Pan, Xiangxiu Liang, et al.. (2025). The kinase CPK5 phosphorylates MICRORCHIDIA1 to promote broad-spectrum disease resistance. The Plant Cell. 37(3). 3 indexed citations
4.
Wang, Chunyang, Jia Liu, Yi Shen, et al.. (2025). Effectiveness and safety of glucocorticoids bridging rituximab in neuromyelitis spectrum disorder. Multiple Sclerosis and Related Disorders. 95. 106314–106314.
5.
Pan, Jing, et al.. (2024). An effective strategy with tofacitinib for the management of focal myositis with rheumatoid arthritis: a case report. Frontiers in Immunology. 15. 1502410–1502410. 1 indexed citations
6.
Zhang, Qi, Xu Chen, Katie Palen, et al.. (2023). Cancer chemoprevention with PV-1, a novel Prunella vulgaris-containing herbal mixture that remodels the tumor immune microenvironment in mice. Frontiers in Immunology. 14. 1196434–1196434. 7 indexed citations
7.
Yu, Guoyu, Paul G. Corn, Pengfei Shen, et al.. (2022). Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition. Cancer Research. 82(17). 3158–3171. 13 indexed citations
8.
Zhang, Qi, Jing Pan, Donghai Xiong, et al.. (2021). Pulmonary Aerosol Delivery of Let‐7b microRNA Confers a Striking Inhibitory Effect on Lung Carcinogenesis through Targeting the Tumor Immune Microenvironment. Advanced Science. 8(17). e2100629–e2100629. 28 indexed citations
9.
Zeng, Zhaoyang, Simin Zhang, Quan Li, et al.. (2020). Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma. SHILAP Revista de lepidopterología. 3 indexed citations
10.
Pan, Jing, et al.. (2020). lncRNA ZFAS1 Is Involved in the Proliferation, Invasion and Metastasis of Prostate Cancer Cells Through Competitively Binding to miR-135a-5p. SHILAP Revista de lepidopterología. 2 indexed citations
11.
Lin, Zhenhua, et al.. (2020). MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Zhang, Qi, Gang Chen, Jing Pan, et al.. (2020). Magnolia extract is effective for the chemoprevention of oral cancer through its ability to inhibit mitochondrial respiration at complex I. Cell Communication and Signaling. 18(1). 58–58. 27 indexed citations
13.
Pan, Jing, Qi Zhang, Katie Palen, et al.. (2019). Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator. EBioMedicine. 49. 72–81. 49 indexed citations
14.
Zhang, Qi, Xu Chen, Jing Pan, et al.. (2019). Optimized Bexarotene Aerosol Formulation Inhibits Major Subtypes of Lung Cancer in Mice. Nano Letters. 19(4). 2231–2242. 15 indexed citations
15.
Pan, Jing, et al.. (2018). Valsartan improves cardiac function in mice with diabetes mellitus by CaMKII/AngII.. PubMed. 22(16). 5327–5334. 5 indexed citations
16.
Pan, Jing, Yongik Lee, Qi Zhang, et al.. (2016). Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway. Cancer Prevention Research. 10(2). 133–141. 42 indexed citations
17.
Xy, Yang, Quan Zhou, Szu‐Yuan Wu, et al.. (2016). High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Zhang, Qi, Jing Pan, Ronald A. Lubet, et al.. (2015). Enhanced Antitumor Activity of 3-Bromopyruvate in Combination with Rapamycin In Vivo and In Vitro. Cancer Prevention Research. 8(4). 318–326. 21 indexed citations
19.
Pan, Jing, et al.. (2015). [Research on child neglect situation and influential factors of left-behind children and living-with-parents children aged 6-17 year-old in rural areas of two provinces, western China].. PubMed. 49(10). 873–8. 5 indexed citations
20.
Zhang, Qi, Jing Pan, Paula E. North, et al.. (2012). Aerosolized 3-Bromopyruvate Inhibits Lung Tumorigenesis without Causing Liver Toxicity. Cancer Prevention Research. 5(5). 717–725. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026